Biological E to Launch Safety Surveillance Study for its Single-Dose Typhoid Vaccine to Detect Adverse Events | Nayi Khabar

Multicentre phase-IV clinical study will be performed in 12 study centres in India. It aims to evaluate the safety of a single intramuscular dose of Biological E’s typhoid conjugate vaccine in participants aged six months to 45 years

from Top India News- News18.com https://ift.tt/17XkcZF
by